
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Chondrosarcoma epidemiology and demographics
Introduction
Overview
Overview
Chondrosarcoma is the second most common malignant primary tumor of bone. It is most frequently diagnosed in patients in their 4th and 5th decades of life. Men are slightly more affected by chondrosarcoma than women. There is no racial predilection to chondrosarcoma.
Epidemiology and Demographics
Epidemiology and Demographics
Incidence
- Chondrosarcoma is the second most common primary bone sarcoma.[1]
- The incidence of chondrosarcoam is approximately 1 per 100,000 individuals worldwide.[2]
Age
- Chondrosarcoma is most frequently diagnosed in patients in their 4th and 5th decades of life.[3]
- The average age at presentation is 51 years.
Race
- There is no racial predilection to chondrosarcoma.[2]
Gender
- Chondrosarcoma affects men and women almost equally with slight male predominance.[4]
- Exception to this is the clear cell sub-type which has significant male preponderance.
- The male to female ratio is almost 1:1 except for clear cell chondrosarcoma it is 2.4:1.
References
References
- β Peabody, Terrance (2014). Orthopaedic oncologyΒ : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBNΒ 9783319073224.
- β 2.0 2.1 Lex JR, Evans S, Stevenson JD, Parry M, Jeys LM, Grimer RJ (2018). “Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment”. Clin Sarcoma Res. 8: 23. doi:10.1186/s13569-018-0110-1. PMCΒ 6293503. PMIDΒ 30559960.
- β Unni KK (2001). “Cartilaginous lesions of bone”. J Orthop Sci. 6 (5): 457β72. PMIDΒ 11845358.
- β Weber KL, Raymond AK (2002). “Low-grade/dedifferentiated/high-grade chondrosarcoma: a case of histological and biological progression”. Iowa Orthop J. 22: 75β80. PMCΒ 1888368. PMIDΒ 12180616.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Rohan A. Bhimani, M.B.B.S., D.N.B., M.Ch.[2]
